November 9, 2020 — AquaBounty Technologies is facing another legal battle over its AquAdvantage salmon, as a California court ruled last week that the Food and Drug Administration (FDA) violated core environmental laws in approving genetically engineered salmon for sale and consumption.
On 5 November, a federal judge in San Francisco ruled the FDA ignored serious possible environmental consequences by approving genetically engineered salmon, and was also violating the National Environmental Policy Act. The judge also ruled the FDA approval was in violation of the Endangered Species Act, as the agency did not consult with the National Marine Fisheries Service and the Fish and Wildlife Service before taking an action that “may affect” a listed or endangered species.